LTBP2 and metastatic malignant neoplasm in the lymph nodes: In univariate analysis, high LTBP2 expression (HR, 4.602, 95% CI: 2.686–7.883; P < 0.001), older age at diagnosis (HR, 1.657, 95% CI: 1.044–2.630; P = 0.032), T stage (HR, 2.047, 95% CI: 1.227–3.414; P = 0.006), histopathological grade (HR, 1.583, 95% CI: 1.129–2.218; P = 0.008), lymph node metastasis (HR, 5.399, 95% CI: 3.508–8.309; P < 0.001), and pTNM stage (HR, 4.842, 95% CI: 3.097–7.571; P < 0.001) were all significantly associated with overall survival.